Toronto Dominion Bank’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$116M Buy
965,000
+821,000
+570% +$94.8M 0.17% 111
2025
Q4
$15.2M Sell
144,000
-264,500
-65% -$24.8M 0.02% 526
2025
Q3
$34.3M Buy
+408,500
New +$33.6M 0.05% 302
2025
Q1
Sell
-8,800
Closed -$875K 1639
2024
Q4
$875K Buy
+8,800
New +$907K ﹤0.01% 1086
2022
Q4
Sell
-80,000
Closed -$6.89M 1563
2022
Q3
$6.89M Buy
+80,000
New +$7.14M 0.01% 584
2019
Q4
Sell
-8,174
Closed -$656K 1476
2019
Q3
$656K Buy
+8,174
New +$655K ﹤0.01% 1009
2016
Q1
Sell
-32,488
Closed -$1.64M 1262
2015
Q4
$1.64M Buy
+32,488
New +$1.64M 0.01% 281

Other funds holding MRK

Toronto Dominion Bank's MRK Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Merck (MRK) stake by 14% in Q1 2026, selling an estimated $18.5M and leaving 961,055 shares worth $116M. The position accounts for 0.17% of the portfolio, ranked #112.

Toronto Dominion Bank first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $480M in Q4 2019. 3,788 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Toronto Dominion Bank held 961,055 shares of Merck worth $116M as of Q1 2026.
  • Toronto Dominion Bank sold 160,593 Merck shares in Q1 2026, an estimated $18.5M.
  • Merck made up 0.17% of Toronto Dominion Bank's portfolio in Q1 2026, its #112 holding.
  • Toronto Dominion Bank first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Toronto Dominion Bank's Merck position peaked at $480M in Q4 2019.
  • 3,788 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.